Stock Performance and Market Context
On 25 Feb 2026, the stock recorded its lowest price in the past year at Rs.11308.35, following two consecutive days of decline before a modest gain today. Despite this slight recovery, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward momentum.
In contrast, the broader market has shown resilience. The Sensex opened 304.20 points higher and climbed further by 381.37 points to close at 82,911.49, up 0.83%. The index is currently 3.92% below its 52-week high of 86,159.02, with mega-cap stocks leading the rally. However, Procter & Gamble Hygiene & Health Care Ltd. underperformed its sector by 0.26% today, reflecting relative weakness within the FMCG space.
Long-Term Performance and Valuation Metrics
Over the past year, the stock has delivered a total return of -15.93%, significantly lagging the Sensex’s 11.09% gain. This underperformance extends over the last three years, with the stock consistently trailing the BSE500 index in annual returns. The 52-week high for the stock was Rs.14,536.60, underscoring the extent of the recent decline.
Financially, the company’s growth has been modest. Net sales have increased at an annualised rate of 5.52% over the last five years, while operating profit has grown at 5.34% annually. Despite this, the company maintains a high return on equity (ROE) of 81.87%, reflecting efficient capital utilisation. However, this strong ROE is accompanied by a very expensive valuation, with a price-to-book (P/B) ratio of 40.1, which is considerably above typical market levels.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Profitability and Efficiency Indicators
Despite the stock’s price decline, the company reported positive quarterly results for the period ending December 2025. Net sales reached a quarterly high of Rs.1,261.90 crore, while PBDIT (profit before depreciation, interest and taxes) also hit a peak at Rs.401.80 crore. The operating profit margin to net sales ratio stood at an impressive 31.84%, indicating strong profitability within the quarter.
The company’s debt profile remains conservative, with an average debt-to-equity ratio of zero, signalling a debt-free balance sheet. This financial prudence supports the company’s operational stability despite the stock’s recent price pressures.
Valuation and Market Sentiment
Procter & Gamble Hygiene & Health Care Ltd.’s current Mojo Score is 43.0, with a Mojo Grade of Sell, downgraded from Hold on 17 Oct 2024. The market capitalisation grade stands at 2, reflecting its mid-cap status. The PEG ratio of 2.2 suggests that the stock’s price is high relative to its earnings growth, which may contribute to cautious sentiment among market participants.
The stock’s valuation is discounted compared to its peers’ historical averages, yet it remains expensive on absolute terms due to its elevated P/B ratio and high ROE. This valuation dynamic has likely influenced the stock’s underperformance relative to the FMCG sector and broader market indices.
Considering Procter & Gamble Hygiene & Health Care Ltd.? Wait! SwitchER has found potentially better options in FMCG and beyond. Compare this mid-cap with top-rated alternatives now!
- - Better options discovered
- - FMCG + beyond scope
- - Top-rated alternatives ready
Shareholding and Sector Position
The majority of shares in Procter & Gamble Hygiene & Health Care Ltd. are held by promoters, indicating a stable ownership structure. The company operates within the FMCG sector, which has generally shown resilience and growth, yet the stock’s performance has lagged behind sector averages.
While the Sensex and mega-cap stocks have driven market gains recently, this stock’s relative underperformance highlights the challenges it faces in regaining investor confidence and aligning with broader market trends.
Summary of Key Metrics
To summarise, the stock’s 52-week low of Rs.11308.35 reflects a combination of modest sales growth, high valuation multiples, and consistent underperformance against benchmarks. Despite strong quarterly profitability and a debt-free balance sheet, the stock remains below all major moving averages and carries a Sell grade from MarketsMOJO, underscoring the cautious stance on its near-term outlook.
The broader market environment remains positive, with the Sensex approaching its 52-week high and mega-cap stocks leading gains. However, Procter & Gamble Hygiene & Health Care Ltd.’s stock price trajectory suggests continued pressure relative to its sector peers and the overall market.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
